Clinical trials
Terminated Hemophilia B trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ApcinteX Ltd | 4 |
| Baxalta now part of Shire | 3 |
| Pfizer | 2 |
| Sangamo Therapeutics | 2 |
| Spur Therapeutics | 2 |
| Avigen | 1 |
| Be Biopharma | 1 |
| Bioverativ Therapeutics Inc. | 1 |
| Children's Mercy Hospital Kansas City | 1 |
| IRCCS Policlinico S. Donato | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia B | 26 |
| Hemophilia A | 14 |
| Afibrinogenemia | 1 |
| Blood Coagulation Disorders | 1 |
| Coagulation Protein Disorders | 1 |
| Heart Defects, Congenital | 1 |
| Hemorrhage | 1 |
| Joint Diseases | 1 |
| Mucopolysaccharidosis I | 1 |
| Mucopolysaccharidosis II | 1 |
Trials
Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.